Eric Aguiar insider trades

Open-market stock purchases and sales by Eric Aguiar, Director at BridgeBio Pharma, Inc, from SEC Form 4 filings since Feb 18, 2015.

Recent trades

DateStockTradeValue
Jun 22, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 22, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 10, 2026BMEA Biomea Fusion, IncBought (not open market)—

Companies traded

  • BBIO BridgeBio Pharma, Inc: other filings, last Jun 22, 2026
  • BMEA Biomea Fusion, Inc: other filings, last Jun 10, 2026
  • NVTA Invitae Corp: 1 buy, 7 sales, last Apr 27, 2023
  • EIDX Eidos Therapeutics, Inc: 2 buys, last May 27, 2020
  • BHVN Biohaven Pharmaceutical Holding Co Ltd: 10 sales, last Jan 22, 2020

Get free alerts when Eric Aguiar files a new trade →